FDA Approved: METOPROLOL — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for metoprolol tartrate from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Cardiac Arrhythmia
• Hypertension
• Myocardial Infarction

Drugs mentioned

• METOPROLOL (METOPROLOL TARTRATE)

Snippet

SUPPL AP for METOPROLOL (METOPROLOL TARTRATE)